The Patent Finder

Flashpoint Therapeutics, Inc.

Also on record
Records under this name other than the patents Flashpoint Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 4 of 4 · Back to Flashpoint Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 11,123,294Multivalent Delivery of Immune Modulators by Liposomal Spherical Nucleic Acids for Prophylactic or Therapeutic Applications
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,434,064Multivalent Delivery of Immune Modulators by Liposomal Spherical Nucleic Acids for Prophylactic or Therapeutic Applications
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,957,788Multivalent Delivery of Immune Modulators by Liposomal Spherical Nucleic Acids for Prophylactic or Therapeutic Applications
Formerly held
In force
 · Low confidence
In forceLow confidence
US 10,760,080Anti-TNF compounds
Lapsed on the fee record
Ended Sep 1, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 1, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited